Senseonics

IPO

Creators of the first and only Long-term Implantable CGM.

Public · Germantown, United States · Founded 1996 · $100.0M raised

Employees
51–200
Founded
1996
Business Model
B2C
Total Funding
$100.0M
Last Round
$20.0M Series AJun 2026
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Senseonics is a publicly traded medical technology company (NYSE: SENS) that develops the Eversense continuous glucose monitoring (CGM) system—the world's first and only long-term implantable CGM for people with diabetes. The Eversense 365 sensor is implanted under the skin and lasts up to 365 days, using fluorescence-based sensing technology paired with a removable smart transmitter and mobile app.

Summary

Senseonics is a Healthcare company based in Germantown, United States, founded in 1996. It has raised $100.0M in total across 2 rounds, most recently a $20.0M Series A round in Jun 2026. Investors include Hercules Capital and Abbott Laboratories.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Series ASeries AJun 2026
$20.0M

Sign up to see all 6 events

Funding: Corporate Round through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
Whoop

Fitness wearable company offering a subscription-based health tracker that measures strain, recov...

Boston, United States501–1000Digital Health, Healthcare
Series G+Total funding$969.4MMar 2026
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Senseonics on Indexed.vc
<a href="https://indexed.vc/companies/senseonics"><img src="https://indexed.vc/api/badge/company/senseonics" alt="Senseonics on Indexed.vc" width="260" height="76" /></a>